A young company.
A 35+ year commitment to injection safety.
ApiJect’s mission is to make injectable medicine safe and available for everyone.
Founded by Marc Koska, who was made an Officer of the Order of the British Empire for his earlier work in injection safety, ApiJect seeks to replace the world’s multi-dose glass vials with safer medical injection formats that will not inadvertently kill or infect tens of millions of people.
To make that possible, Mr. Koska invented the ApiJect Prefilled Injector – a prefilled single-use injection device that brings together the manufacturing efficiency and quality of Blow-Fill-Seal drug packaging with a modified pen needle hub. He then teamed up with Jay Walker, an internationally recognized entrepreneur who has founded three companies with 50 million customers (most well-known is Priceline, now Bookings Holdings).
Today, ApiJect is a rapidly growing medical technology company revolutionizing how the world gets injectable vaccine and medicines – whether it is for pandemic defense, branded and generic pharmaceuticals, or global health. In partnership with the U.S. Government, ApiJect is a founding member of The RAPID Consortium, whose purpose is to give America and its allies “surge capacity” for supplying vaccine and medicine in individual doses for injection — a capacity that strengthens population-scale defense against pandemics and other bio-emergencies.
Pandemic Defense
The global supply chain for injectable medicines was never built to handle the filling and packaging required for COVID-19 vaccines. The world is likely to need more than 10 billion doses to combat the pandemic over the next couple of years. Learn how the U.S. Government and ApiJect are working together to address this problem.
Want to join a young company with audacious missions and enormous passion? See what positions are open.